These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9869584)

  • 1. Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1,500 milligrams, given over a 3- or 5-day period in healthy subjects.
    Amsden GW; Nafziger AN; Foulds G
    Antimicrob Agents Chemother; 1999 Jan; 43(1):163-5. PubMed ID: 9869584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers.
    Amsden GW; Gray CL
    J Antimicrob Chemother; 2001 Jan; 47(1):61-6. PubMed ID: 11152432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen.
    Liu P; Allaudeen H; Chandra R; Phillips K; Jungnik A; Breen JD; Sharma A
    Antimicrob Agents Chemother; 2007 Jan; 51(1):103-9. PubMed ID: 17060516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of azithromycin leukocyte disposition in healthy volunteers and volunteers with AIDS.
    McNabb J; Owens RC; Xuan D; Quintiliani R; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2000 Sep; 16(1):37-43. PubMed ID: 11185411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis.
    Bui KQ; McNabb J; Li C; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2302-4. PubMed ID: 10471584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions.
    Wildfeuer A; Laufen H; Zimmermann T
    Antimicrob Agents Chemother; 1996 Jan; 40(1):75-9. PubMed ID: 8787883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.
    Zheng S; Matzneller P; Zeitlinger M; Schmidt S
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6675-84. PubMed ID: 25155592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tissue concentrations of azithromycin in ball pythons (Python regius).
    Coke RL; Hunter RP; Isaza R; Koch DE; Goatley MA; Carpenter JW
    Am J Vet Res; 2003 Feb; 64(2):225-8. PubMed ID: 12602593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and transplacental pharmacokinetics of azithromycin.
    Ramsey PS; Vaules MB; Vasdev GM; Andrews WW; Ramin KD
    Am J Obstet Gynecol; 2003 Mar; 188(3):714-8. PubMed ID: 12634646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of azithromycin pharmacokinetics in healthy volunteers in open cross randomized procedure].
    Pisarev VV; Moskaleva NE; Zverkov IuB; Smirnova LB; Belolipetskaia VG; Sukhanov IaV
    Antibiot Khimioter; 2003; 48(10):7-10. PubMed ID: 15004973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue tolerance of azithromycin after intramuscular administration to rabbits.
    Escudero E; Fernández-Varón E; Marín P; Espuny A; Nájera MD; Cárceles CM
    Res Vet Sci; 2006 Dec; 81(3):366-72. PubMed ID: 16530237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes.
    Davis JL; Gardner SY; Jones SL; Schwabenton BA; Papich MG
    J Vet Pharmacol Ther; 2002 Apr; 25(2):99-104. PubMed ID: 12000529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and preliminary safety evaluation of azithromycin in adult horses.
    Leclere M; Magdesian KG; Cole CA; Szabo NJ; Ruby RE; Rhodes DM; Edman J; Vale A; Wilson WD; Tell LA
    J Vet Pharmacol Ther; 2012 Dec; 35(6):541-9. PubMed ID: 22136612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats.
    Cárceles CM; Font A; Espuny A; Fernández-Varón E; Serrano JM; Escudero E
    J Vet Pharmacol Ther; 2005 Feb; 28(1):51-5. PubMed ID: 15720515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals.
    Jacks S; Giguère S; Gronwall PR; Brown MP; Merritt KA
    Am J Vet Res; 2001 Dec; 62(12):1870-5. PubMed ID: 11763173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients.
    Blandizzi C; Malizia T; Batoni G; Ghelardi E; Baschiera F; Bruschini P; Senesi S; Campa M; Del Tacca M
    Antimicrob Agents Chemother; 2002 May; 46(5):1594-6. PubMed ID: 11959610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin pharmacokinetics in the serum and its distribution to the skin in healthy dogs and dogs with pyoderma.
    Zur G; Soback S; Weiss Y; Perry E; Lavy E; Britzi M
    Vet J; 2014 Apr; 200(1):122-6. PubMed ID: 24472431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Azithromycin on Venetoclax Pharmacokinetics in Healthy Volunteers: Implications for Dosing Venetoclax with P-gp Inhibitors.
    Agarwal SK; Tong B; Bueno OF; Menon RM; Salem AH
    Adv Ther; 2018 Nov; 35(11):2015-2023. PubMed ID: 30264382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses.
    Olsen KM; San Pedro G; Gann LP; Gubbins PO; Halinski DM; Campbell GD
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2582-5. PubMed ID: 8913469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of macrolides. Comparison of plasma, tissue and free concentrations with special reference to roxithromycin.
    Nilsen OG
    Infection; 1995; 23 Suppl 1():S5-9. PubMed ID: 7782117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.